Do‐Hyun Nam

1997–2025 年に発表

別表記
Do-Hyun Nam · Do Hyun Nam
147
論文数
20,782
被引用数
81
h 指数
140
i10 指数

被引用数

Do‐Hyun Nam の年別被引用数1994 年: 被引用 1 件2000 年: 被引用 3 件2001 年: 被引用 1 件2002 年: 被引用 3 件2004 年: 被引用 1 件2005 年: 被引用 2 件2006 年: 被引用 11 件2007 年: 被引用 14 件2008 年: 被引用 31 件2009 年: 被引用 65 件2010 年: 被引用 82 件2011 年: 被引用 109 件2012 年: 被引用 123 件2013 年: 被引用 136 件2014 年: 被引用 141 件2015 年: 被引用 169 件2016 年: 被引用 188 件2017 年: 被引用 283 件2018 年: 被引用 230 件2019 年: 被引用 797 件2020 年: 被引用 983 件2021 年: 被引用 1,173 件2022 年: 被引用 911 件2023 年: 被引用 688 件2024 年: 被引用 1,036 件2025 年: 被引用 469 件2026 年: 被引用 16 件1995〜1999 年は被引用が無いため表示していません2003 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,430 件、この内訳の 24%中国: 引用元論文 1,974 件、この内訳の 19.5%ドイツ: 引用元論文 550 件、この内訳の 5.4%イタリア: 引用元論文 487 件、この内訳の 4.8%イギリス: 引用元論文 428 件、この内訳の 4.2%韓国: 引用元論文 424 件、この内訳の 4.2%フランス: 引用元論文 286 件、この内訳の 2.8%カナダ: 引用元論文 285 件、この内訳の 2.8%スイス: 引用元論文 238 件、この内訳の 2.3%オランダ: 引用元論文 223 件、この内訳の 2.2%スペイン: 引用元論文 222 件、この内訳の 2.2%日本: 引用元論文 218 件、この内訳の 2.2%
0%24%その他 23.4%

分野

  • Medicine50.6%
  • Biochemistry, Genetics and Molecular Biology35.1%
  • Immunology and Microbiology4.5%
  • Neuroscience2.3%
  • Materials Science2.2%
  • Engineering2.2%
  • その他3.1%

トピック

  • Glioma Diagnosis and Treatment10.6%
  • Cancer Cells and Metastasis3.5%
  • Cancer Genomics and Diagnostics3.2%
  • Epigenetics and DNA Methylation2.7%
  • MicroRNA in disease regulation2.6%
  • Immune cells in cancer2.4%
  • その他75%

共著者

全論文

検索で開く
  1. Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Burt Nabors, David A. Reardon, Martin J. van den Bent, Christine Hicking, Andriy Markivskyy, Martin Picard, Michael Weller - The Lancet Oncology 2014 被引用: 1,019

  2. Longitudinal molecular trajectories of diffuse glioma in adults

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Fletcher, Pim J. French, Hui K. Gan, Mark R. Gilbert, Peter V. Gould, Matthew Grimmer, Antonio Iavarone, Azzam Ismail, Michael D. Jenkinson, Mustafa Khasraw, Hoon Kim, Mathilde C. M. Kouwenhoven, Peter S. LaViolette, Meihong Li, Peter Lichter, Keith L. Ligon, Allison K. Lowman, Tathiane M. Malta, Tali Mazor, Kerrie L. McDonald, Annette M. Molinaro, Do-Hyun Nam, Naema Nayyar, Ho‐Keung Ng, Chew Yee Ngan, Simone P. Niclou, Johanna M. Niers, Houtan Noushmehr, Javad Noorbakhsh, D. Ryan Ormond, Chul‐Kee Park, Laila Poisson, Raúl Rabadán, Bernhard Radlwimmer, Ganesh Rao, Guido Reifenberger, K. Jason, Michael Schuster, Brian Shaw, Susan Short, Peter A. Sillevis Smitt, Andrew E. Sloan, Marion Smits, Hiromichi Suzuki, Ghazaleh Tabatabai, Erwin G. Van Meir, Colin Watts, Michael Weller, Pieter Wesseling, Bart A. Westerman, Georg Widhalm, Adelheid Woehrer, W. K. Alfred Yung, Gelareh Zadeh, Jason T. Huse, John de Groot, Lucy F. Stead, Roel G.W. Verhaak, Floris P Barthel, Kevin C. Johnson, Frederick S. Varn, Anzhela D. Moskalik, Georgette Tanner, Emre Kocakavuk, Kevin J. Anderson, Kenneth Aldape, Kristin Alfaro-Munoz, Samirkumar B. Amin, David M. Ashley, Pratiti Bandopadhayay ほか 63 名 - Nature, Nat. 2019 被引用: 609

  3. Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alison Y. Zhang, Hans Prenen, Jean‐Charles Goeminne, Jean‐Pascal Machiels, Sylvie Rottey, Marcelo Corassa, Graziela Zibetti Dal Molin, Katsuki Arima Tiscoski, Denis L. Jardim, Milena Perez Mak, Wei Fu, Herui Yao, Jing Huang, Haiping Jiang, Jing Huang, Baoshi Chen, Dong Yan, Yu Yang, Yohann Loriot, Christophe Le Tourneau, Nicolas Penel, Sébastien Salas, Jean‐Yves Blay, Pierre-Emmanuel Brachet, Xavier Durando, Sheik Emambux, Alain Ravaud, Gunnar Folprecht, Dirk Arnold, Martin Schüler, Marit Ahrens, Alexander Golf, Georg Martin Haag, Florian Lordick, Alexander Desuki, Marina Elena Cazzaniga, Fortunato Ciardiello, Michèle Milella, Takafumi Koyama, Yoshiki Hirooka, Wataru Okamoto, Kenjiro Aogi, Yasutoshi Kuboki, Jung-Yun Lee, Sung‐Bae Kim, Myung‐Ju Ahn, Jong Hee Chang, Yongman Kim, Do‐Hyun Nam, Jaesung Park, Iwona Ługowska, Luis Paz‐Ares, Víctor Moreno, Andrés Cervantes, Mariona Calvo, Alejandro Falcón, Antonio González, Josep Tabernero, A. Martinez Bueno, Javier García-Corbacho, Federico Longo, Chia‐Jui Yen, Jen‐Shi Chen, Ming‐Feng Hou, Yee Chao, Kun‐Ming Rau, Tai‐Jan Chiu, Yin‐Hsun Feng, Chih‐Hung Hsu, Wen‐Tsung Huang ほか 33 名 - The Lancet Oncology 2023 被引用: 200

  4. Clinical practice guidelines for the management of adult diffuse gliomas

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yiwu Dai, Shengqing Lv, Liang Wang, Zhixiong Lin, Jun Dong, Guozheng Xu, Xiaodong Ma, Wei Zhang, Chuanbao Zhang, Baoshi Chen, Gan You, Yongzhi Wang, Yinyan Wang, Zhaoshi Bao, Pei Yang, Xing Fan, Xing Liu, Zheng Zhao, Zheng Wang, Yiming Li, Zhiliang Wang, Guanzhang Li, Shengyu Fang, Lianwang Li, Yanwei Liu, Shuai Liu, Xia Shan, Yuqing Liu, Ruichao Chai, Huimin Hu, Jing Chen, Wei Yan, Jinquan Cai, Hongjun Wang, Lingchao Chen, Yuan Yang, Yu Wang, Lei Han, Qixue Wang - Cancer Letters 2020 被引用: 473

  5. Clonal evolution of glioblastoma under therapy

    著者: , , , , , , , , , , , , , , , , , , , - Nature Genetics 2016 被引用: 790

  6. Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tao Jiang - Cell 2018 被引用: 365

  7. Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells

    著者: , , , , , , , , , , , , , , - Cancer Cell 2013 被引用: 812

  8. Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2018 被引用: 325

  9. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Amy B. Heimberger, Erik P. Sulman, Do‐Hyun Nam, Roel G.W. Verhaak - Cancer Cell 2017 被引用: 2,067

  10. Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma

    著者: , , , , , , , , , , , , , , , , , , - Nature Genetics 2018 被引用: 326

  11. ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2020 被引用: 138

  12. Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Do‐Hyun Nam, Ichiro Nakano, Krishna Bhat - Cell Reports 2019 被引用: 219

  13. Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guido Reifenberger, Federico Roncaroli, K. Jason, Peter A.E. Sillevis Smitt, Marion Smits, Camila Ferreira de Souza, Ghazaleh Tabatabai, Erwin G. Van Meir, Roel G.W. Verhaak, Colin Watts, Pieter Wesseling, Adelheid Wöehrer, W.K. Alfred Yung, Christine Jungk, Ann‐Christin Hau, Eric Van Dyck, Bart A. Westerman, Julia Yin, Olajide Abiola, Nikolajs Zeps, Sean M. Grimmond, Michael E. Buckland, Mustafa Khasraw, Erik P. Sulman, Andrea Muscat, Lucy F. Stead - Neuro-Oncology 2018 被引用: 202

  14. Integrated proteogenomic characterization of glioblastoma evolution

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ho Shin Gwak, Anna Lasorella, Heon Yoo, Marc Sanson, K. Jason, Chul-Kee Park, Do‐Hyun Nam, Antonio Iavarone, Jong Bae Park - Cancer Cell 2024 被引用: 91

  15. MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas

    著者: , , , , , , , , , , , , , , , , , , - Nature Communications 2020 被引用: 198

  16. Single-cell RNA sequencing reveals the tumor microenvironment and facilitates strategic choices to circumvent treatment failure in a chemorefractory bladder cancer patient

    著者: , , , , , , , , , , , - Genome Medicine 2020 被引用: 196

  17. Tissue factor is a critical regulator of radiation therapy-induced glioblastoma remodeling

    著者: , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2023 被引用: 81

  18. TP53 gain-of-function mutation promotes inflammation in glioblastoma

    著者: , , , , , , , , , , , , , , , , - Cell Death and Differentiation 2018 被引用: 225

  19. Spatiotemporal Evolution of the Primary Glioblastoma Genome

    著者: , , , , , , , , , , , , , , , , , - Cancer Cell 2015 被引用: 321

  20. Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy

    著者: , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2020 被引用: 169

  21. Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2015 被引用: 207

  22. Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Lim, Jong Bae Park, Antonio Iavarone, Roel G.W. Verhaak, Do‐Hyun Nam - Genome biology 2020 被引用: 109

  23. A tension-mediated glycocalyx–integrin feedback loop promotes mesenchymal-like glioblastoma

    著者: , , , , , , , , , , , , , , , , , , , , , - Nature Cell Biology 2018 被引用: 176

  24. Spatiotemporal genomic architecture informs precision oncology in glioblastoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2017 被引用: 288